Phase 2 Microsatellite Stable Metastatic Colorectal Cancer Clinical Trials
3 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–3 of 3 trials
Recruiting
Phase 2
Personalized Ultrafractionated Stereotactic Adaptive Radiotherapy (PULSAR ) Combined With Anti-PD1，Chemotherapy and Target Therapy for Metastatic Colorectal Cancer
Microsatellite Stable Metastatic Colorectal Cancer
Fudan University116 enrolled1 locationNCT06841159
Recruiting
Phase 2
Regorafenib Alone or in Combination With Hypofractionated/Low-dose Radiotherapy Plus Toripalimab for Metastatic Colorectal Cancer
Microsatellite Stable Metastatic Colorectal Cancer
Fudan University108 enrolled1 locationNCT05963490
Recruiting
Phase 2
Standard Systemic Therapy Combined With High/Low-dose Radiotherapy Plus Toripalimab for Metastatic Colorectal Cancer
Microsatellite Stable Metastatic Colorectal Cancer
Fudan University96 enrolled1 locationNCT06525428